Dx & Vx Co., Ltd.
Develops innovative diagnostics & vaccines and provides comprehensive life science contract services.
180400 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 금천구 디지털로 173, 금천구
- Website:
- https://www.dxvx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Dx & Vx Co., Ltd. is a global bio-healthcare company focused on developing innovative diagnostics (Dx) and vaccines (Vx). The company leverages proprietary technologies, including a platform for long-term, room-temperature storage of mRNA vaccines and a universal Next-Generation Sequencing (NGS) platform. Its R&D pipeline targets infectious diseases, immuno-oncology, obesity, and eye diseases. In addition to its drug development, Dx & Vx provides a comprehensive suite of services to the life sciences industry, including contract development (CDO), manufacturing (CMO), sales (CSO), and companion diagnostics (CDx) development. The company also develops microbiome-based products and offers medical data services.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-16 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의 (임시주주총회)
|
Korean | 8.4 KB | ||
| 2025-09-16 00:00 |
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
|
Korean | 4.7 KB | ||
| 2025-08-29 00:00 |
M&A Activity
합병등종료보고서(자산양수도)
|
Korean | 15.2 KB | ||
| 2025-08-14 00:00 |
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
|
Korean | 13.3 KB | ||
| 2025-08-14 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.8 MB | ||
| 2025-08-14 00:00 |
Audit Report / Information
반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)
|
Korean | 12.1 KB | ||
| 2025-08-14 00:00 |
Annual Report
[기재정정]사업보고서 (2024.12)
|
Korean | 2.4 MB | ||
| 2025-07-30 00:00 |
M&A Activity
투자판단관련주요경영사항 (mRNA항암백신 공동연구 및 기술이전계약 체결)
|
Korean | 10.7 KB | ||
| 2025-07-30 00:00 |
M&A Activity
주요사항보고서(타법인주식및출자증권양도결정)
|
Korean | 19.8 KB | ||
| 2025-07-21 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
|
Korean | 82.4 KB | ||
| 2025-05-27 00:00 |
Capital/Financing Update
단기차입금증가결정
|
Korean | 9.2 KB | ||
| 2025-05-23 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.1 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.6 MB | ||
| 2025-05-08 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.0 KB | ||
| 2025-05-02 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
|
Korean | 74.5 KB |
Automate Your Workflow. Get a real-time feed of all Dx & Vx Co., Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Dx & Vx Co., Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
